Monday, September 30, 2019

Ranitidine controversy: Which Indian pharma companies stand to lose?

Ranitidine controversy: Which Indian pharma companies stand to lose? NULL

from Moneycontrol Business News https://ift.tt/2nRJ8ks

No comments:

Post a Comment

Vedanta, Hindustan Zinc shares fall after metals giant confirms ED visits to offices

Vedanta and Hindustan Zinc shares dipped after the Enforcement Directorate visited some of their offices as part of a FEMA probe. The compan...